A Study of JNJ-63898081 in Participants With Advanced Stage Solid Tumors
Clinical trial NCT03926013 · COMPLETED
Trial details
- NCT number
- NCT03926013
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-08-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.